secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001175680-26-000002
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn holds investor call for corporate and clinical update; no material results disclosed in filing
--------------------------------------------------------------------------------

- Company held investor call on April 30, 2026 at 1:00 p.m. PT to provide corporate and clinical update.
- Presentation materials furnished as Exhibit 99.1 titled 'Leronlimab – A Novel Therapeutic in CCR5+ Immuno-Oncology'.
- No specific financial or trial data included in the 8-K or exhibit; update is forward-looking without new quantitative details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000117568026000002/0001175680-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000117568026000002/ck0001175680-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001175680-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer